Changing disease burden and management issues for esophageal cancer in the Asia-Pacific region

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 4, 2002, Pages 374-381

  Law, Simon ^a   Wong, John ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adenocarcinoma; Barrett's esophagus; Endoscopic therapy; Epidemiology; Esophageal neoplasm; Multimodality treatment; Squamous cell carcinoma; Surgery

Indexed keywords

CISPLATIN; DNA TOPOISOMERASE INHIBITOR; DOCETAXEL; FLUOROURACIL; GEMCITABINE; IRINOTECAN; NAVELBINE; PACLITAXEL; TAXANE DERIVATIVE; TOPOTECAN;

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ANASTOMOSIS LEAKAGE; ASIA; BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER GROWTH; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CARDIA; CLINICAL TRIAL; CONFERENCE PAPER; DEVELOPING COUNTRY; EARLY DIAGNOSIS; ENDOSCOPIC SURGERY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; LIFE EXPECTANCY; LYMPHADENECTOMY; MULTIMODALITY CANCER THERAPY; PACIFIC ISLANDS; PHOTODYNAMIC THERAPY; PRECANCER; PRIORITY JOURNAL; SOCIOECONOMICS; SQUAMOUS CELL CARCINOMA; STENT; SURGICAL MORTALITY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036091660     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02728.x     Document Type: Conference Paper

References (110)

1. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction
2. Rising incidence of adenocarcinoma of the esophagus and gastric cardia
3. Continuing climb in rates of esophageal adenocarcinoma: An update
4. Gastro-oesophageal reflux disease in Asia
5. Helicobacter pylori: A debated factor in gastroesophageal reflux disease
6. A guide for surveillance of patients with Barrett's esophagus
7. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients
8. Laparoscopy and laparoscopic ultrasonography in staging of carcinoma of the esophagus and gastric cardia
9. Does lymphadenectomy add anything to the treatment of esophageal cancer?
10. China's census. National count reveals major societal changes
11. Age-standardized cancer incidence rates in Japan
12. Risk analysis in resection of squamous cell carcinoma of the esophagus
13. Surgical aspects of carcinoma of the esophagus
14. Oesophageal squamous cell carcinoma: I a critical review of surgery
15. Surgical therapy of oesophageal carcinoma
16. Surgical management of esophageal cancer: The Western experience
17. Esophagectomy for carcinoma of the esophagus in the elderly: Results of current surgical management
18. Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus
19. Transhiatal esophagectomy: Clinical experience and refinements
20. Analysis of reduced death and complication rates after esophageal resection
21. Operable squamous esophageal cancer: Current results from the East
22. Radical lymph node dissection for cancer of the thoracic esophagus
23. Selective therapeutic approach to cancer of the lower esophagus and cardia
24. Postoperative analgesia reduces mortality and morbidity after esophagectomy
25. Influence of thoracic epidural analgesia on outcome after resection for esophageal cancer
26. Effect of surgical experience on the results of resection for oesophageal carcinoma
27. A hospital's annual rate of esophagectomy influences the operative mortality rates
28. Learning curve for oesophageal cancer surgery
29. Impact of hospital volume on operative mortality for major cancer surgery
30. Comparison of hand-sewn and stapled esophagogastric anastomosis after esophageal resection for cancer: A prospective randomized controlled trial
31. Critical appraisal of the significance of intrathoracic anastomotic leakage after esophagectomy for cancer
32. What is appropriate treatment for carcinoma of the thoracic esophagus?
33. Radical transhiatal oesophagectomy under direct vision
34. Transhiatal esophagectomy for esophageal cancer
35. Adenocarcinoma of the gastroesophageal junction: Classification, pathology and extent of resection
36. Systemic lymph node dissection for esophageal cancer - Effective or not?
37. Oesophagectomy by a transhiatal approach or thoracotomy: A prospective randomized trial
38. A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma
39. Transhiatal versus Ivor-Lewis oesophagectomy: Is there a difference?
40. Transthoracic versus transhiatal resection for carcinoma of the esophagus: A meta-analysis
41. Evaluation of neck lymph node dissection for thoracic esophageal carcinoma
42. A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus
43. Thoracoscopic esophagectomy for esophageal cancer
44. Thoracoscopic esophageal mobilization for pharyngolaryngoesophagectomy
45. Thoracoscopic dissection of the esophagus for cancer
46. Right thoracoscopically assisted oesophagectomy for cancer
47. Thoracoscopic subtotal oesophagectomy
48. En bloc and standard esophagectomies by thoracoscopy
49. Can the morbidity of esophagectomy be reduced by the thoracoscopic approach?
50. Video-assisted thoracoscopic esophagectomy for esophageal cancer
51. Radical transhiatal esophagectomy with two-field lymphadenectomy and endodissection for distal esophageal adenocarcinoma
52. No obvious advantages for thoracoscopic two-stage esophagectomy
53. Endoscopic cervico-thoraco-abdominal esophagectomy
54. Laparoscopic total esophagectomy
55. Radical thoracoscopic esophagectomy for cancer
56. Thoracoscopic en bloc total esophagectomy with radical mediastinal lymphadenectomy
57. Endodissection of the thoracic esophagus. Technique and clinical results in transhiatal esophagectomy
58. Parietal seeding of esophageal cancer after thoracoscopic resection
59. Port-site recurrence after thoracoscopic resection of oesophageal cancer
60. Multimodal therapy for squamous carcinoma of the oesophagus
61. Preoperative radiotherapy for carcinoma of the esophagus
62. A prospective randomized study on radiotherapy and surgery in the treatment of oesophageal carcinoma
63. The value of preoperative radiotherapy in esophageal cancer: Results of a study of the E.O.R.T.C
64. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: Report on 206 patients
65. Low dose preoperative radiotherapy for carcinoma of the oesophagus: Results of a randomized clinical trial
66. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre- operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer
67. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial
68. Postoperative radiotherapy for carcinoma of the esophagus: A prospective, randomized controlled study
69. Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: A prospective randomized study
70. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus
71. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus
72. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: A prospective randomized trial
73. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer
74. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: Final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone
75. Medical Research Council (MRC) randomised phase III trial of surgery with or without preoperative chemotherapy in resectable cancer of the oesophagus
76. Preoperative (neo-adjuvant) chemoradiotherapy in oesophageal cancer
77. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma
78. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus
79. A prospective study of combined therapy in esophageal cancer
80. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma
81. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus
82. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus
83. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study
84. Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01)
85. The evaluation and treatment of patients receiving radiation therapy for carcinoma of the esophagus: Results of the 1992-94 Patterns of Care Study
86. Outcome of patients receiving radiation for cancer of the esophagus: Results of the 1992-94 Patterns of Care Study
87. Esophageal cancer. Results of an American College of Surgeons Patient Care Evaluation Study
88. Chemoradiotherapy - Panacea for esophageal cancer? Commentary for Chemoradiotherapy of locally advanced esophageal cancer. Long-term follow-up of a prospective randomized trial (RTOG 85-01)
89. Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus
90. Preliminary results of Intergroup INT 0123 randomized trial of combined modality therapy (CMT) for esophageal cancer: Standard vs. high dose radiation therapy
91. Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy
92. Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer
93. Objective evaluation of the quality of palliation in patients with oesophageal cancer comparing surgery, radiotherapy and intubation
94. Multimodal treatment for squamous cell esophageal cancer
95. Phase I study of paclitaxel and day 1/day 8 gemcitabine in patients with solid malignancies
96. New adjuvant therapies for esophageal cancer
97. Endoscopic mucosal resection for esophageal and gastric mucosal cancers
98. Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract
99. Esophageal self-expandable metallic stents - Indications, practice, techniques, and complications: Results of a national survey
100. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer
101. Plastic prosthesis versus expandable metal stents for palliation of inoperable esophageal thoracic carcinoma: A controlled prospective study
102. Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: A controlled, prospective study
103. The cost effectiveness of metal oesophageal stenting in malignant disease compared with conventional therapy
104. Palliation of inoperable esophageal carcinoma: A prospective randomized trial of laser therapy and stent placement
105. Esophageal stent with antireflux valve for tumors involving the cardia: Work in progress
106. Endoscopic prosthesis implantation in stenoses and fistulas of the proximal cervical esophagus
107. Self-expanding metallic stents for palliation of recurrent malignant esophageal obstruction after subtotal esophagectomy for cancer
108. Nonmalignant obstruction is a common problem with metal stents in the treatment of esophageal cancer
109. Mucosal ablation therapy of barrett esophagus